Sinusoidal endothelial cell and parenchymal cell injury during endotoxemia and hepatic ischemia-reperfusion: Protection by the 21-aminosteroid tirilazad mesylate

International Hepatology Communications

Volumn 6, Issue 3-4, 1997, Pages 121-129

  Fisher, Michael A ^a   Eversole, Robert R ^b   Beuving, Leonard J ^b   Jaeschke, Hartmut ^a  

^a PFIZER INC   (United States)

^b WESTERN MICHIGAN UNIVERSITY   (United States)

Author keywords

inflammation; Kupffer cells; liver failure; multiple organ failure; neutrophils; plasma hyaluronic acid; sepsis

Indexed keywords

21 AMINOSTEROID; TIRILAZAD;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTRON MICROSCOPY; ENDOTHELIUM CELL; INFLAMMATION; INTRAVENOUS DRUG ADMINISTRATION; KUPFFER CELL; LIVER FAILURE; LIVER PROTECTION; LIVER SINUSOID; MALE; MULTIPLE ORGAN FAILURE; NONHUMAN; PRIORITY JOURNAL; RAT; SALMONELLA ENTERITIDIS;

EID: 0031040276     PISSN: 09284346     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-4346(96)00337-4     Document Type: Article

References (23)

1. [1] Anderson BO, Harken AH. Multiple organ failure: Inflammatory priming and activation sequences promote autologous tissue injury. J Trauma 1990; 30: S44-S49.
2. [2] Liu P, Vonderfecht SL, Fisher MA, McGuire GM, Jaeschke H. Priming of phagocytes for reactive oxygen production during hepatic ischemia and reperfusion increases the susceptibility for endotoxin-induced liver injury. Circ Shock 1994; 43: 9-17.
3. [3] McGuire GM, Liu P, Jaeschke H. Neutrophil-induced lung damage after hepatic ischemia and endotoxemia. Free Radical Biol Med 1996; 20: 189-197.
4. [4] Liu P, Vonderfecht SL, McGuire GM, Fisher MA, Farhood A, Jaeschke H. The 21-aminosteroid tirilazad mesylate protects in a model of endotoxin shock and acute liver failure in rats. J Pharmacol Exp Ther 1994; 271: 438-445.
5. [5] Jaeschke H, Farhood A. Neutrophil and Kupffer cell-induced oxidant stress and ischemia-reperfusion injury in rat liver in vivo. Am J Physiol 1991; 260: G355-G362.
6. [6] Liu P, McGuire GM, Fisher MA, Farhood A, Smith CW, Jaeschke H. Activation of Kupffer cells and neutrophils for reactive oxygen formation is responsible for endotoxin-enhanced liver injury after hepatic ischemia. Shock 1995; 3: 56-62.
7. [7] Mochida S, Arai M, Ohno A, Masaki N, Ogata I, Fujiwara K. Oxidative stress in hepatocytes and stimulatory state of Kupffer cells after reperfusion differ between warm and cold ischemia in rats. Liver 1994; 14: 234-240.
8. [8] Jaeschke H, Bautista AP, Spolarics Z, Spitzer JJ. Superoxide generation by neutrophils and Kupffer cells during in vivo reperfusion after hepatic ischemia in rats. J Leukocyte Biol 1992; 52: 377-382.
9. [9] Jaeschke H, Farhood A, Bautista AP, Spolarics Z, Spitzer JJ. Complement activates Kupffer cells and neutrophils during reperfusion after hepatic ischemia. Am J Physiol 1993; 264: G801-G809.
10. [10] Jaeschke H, Farhood A, Smith CW. Neutrophils contribute to ischemia-reperfusion injury in rat liver in vivo. FASEB J 1990; 4: 3355-3359.
11. [11] Smedsrod B. Non-invasive means to study the functional status of sinusoidal liver endothelial cells. J Gastroenterol Hepatol 1995; 10: S81-S83.
12. [12] Wang Y, Mathews WR, Guido DM, Jaeschke H. Inhibition of nitric oxide synthesis aggravates reperfusion injury after hepatic ischemia and endotoxemia. Shock 1995; 4: 282-288.
13. [13] Deaciuc IV, Bagby GJ, Lang CH, Skrepnik N, Spitzer JJ. Gram-negative bacterial lipopolysaccharide impairs hyaluronan clearance in vivo and its uptake by the isolated perfused rat liver. Hepatology 1993; 18: 173-178.
14. [14] Mochida S, Ogata I, Hirata K, Ohta Y, Yamada S, Fujiwara K. Provocation of massive hepatic necrosis by endotoxin after partial hepatectomy in rats. Gastroenterology 1990; 99: 771-777.
15. [15] Arai M, Mochida S, Ohno A, Ogata I, Fujiwara K. Sinusoidal endothelial cell damage by activated macrophages in rat liver necrosis. Gastroenterology 1993; 104: 1466-1471.
16. [16] McCuskey PA, McCuskey RS. Electron microscopic study of the effects of endotoxin on the cells of the hepatic sinusoid in normal and BCG sensitized mice. Histol Histopathol 1991; 6: 353-362.
17. [17] Hall ED, McCall JM, Means ED. Therapeutic potential of the lazaroids (21-aminosteroids) in acute central nervous system trauma, ischemia and subarachnoid hemorrhage. Adv Pharmacol 1994; 28: 221-268.
18. [18] Dimmeler S, Brinkmann S, Neugebauer E. Endotoxin-induced changes of endothelial cell viability and permeability: protective effect of 21-aminosteroid. Eur J Pharmacol 1995; 287: 257-261.
19. [19] Eversole R, Smith SL, Beuving LJ, Hall ED. Protective effect of the 21-aminosteroid lipid peroxidation inhibitor tirilazad mesylate (U-74006F) on hepatic endothelium in hemorrhagic shock. Circ Shock 1993; 40: 125-131.
20. [20] Cosenza CA, Cramer DV, Cunneen SA, Tuso PJ, Wang HK, Makowka L. Protective effect of the lazaroid U-74006F in cold ischemia-reperfusion injury of the liver. Hepatology 1994; 19: 418-425.
21. [21] McKenna RM, Laskey RE, Wang Y, Jaeschke H, Mathews WR. Effect of endotoxin enhanced hepatic reperfusion injury on endothelium-dependent relaxation in rat aorta. Shock 1996; 6: 106-111.
22. [22] Wang Y, Mathews WR, Guido D, Jaeschke H. The 21-aminosteroid tirilazad mesylate protects against liver injury via membrane stabilization not inhibition of lipid peroxidation. J Pharmacol Exp Ther 1996; 277: 714-720.
23. [23] Yamada S, Ogata I, Hirata K, Mochida S, Tomiya T, Fujiwara K. Intravascular coagulation in the development of massive hepatic necrosis induced by Corynebacterium parvum and endotoxin in rats. Scand J Gastroenterol 1989; 24: 293-298.